Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-03-25 4:12 pm Purchase | 13G | REV GROUP INC REVG | CITADEL ADVISORS LLC | 2,697,273 5.2% | 2,697,273 (New Position) | View |
2024-03-22 4:43 pm Purchase | 13G | CUMMINS INC CMI | CITADEL ADVISORS LLC | 263,557 0.2% | 263,557 (New Position) | View |
2024-03-18 4:13 pm Purchase | 13G | ATARA BIOTHERAPEUTICS INC ATRA | CITADEL ADVISORS LLC | 6,533,119 6.4% | 6,533,119 (New Position) | View |
2024-02-23 4:01 pm Purchase | 13G | HELIX ACQUISITION CORP II HLXB | CITADEL ADVISORS LLC | 1,322,155 7% | 1,322,155 (New Position) | View |
2024-02-14 6:18 pm Purchase | 13G | LYRA THERAPEUTICS INC LYRA | CITADEL ADVISORS LLC | 4,286,927 7.9% | 1,390,392 (+48.00%) | View |
2024-02-14 6:18 pm Sale | 13G | JASPER THERAPEUTICS INC JSPR | CITADEL ADVISORS LLC | 230,620 0.2% | -3,498,450 (-93.82%) | View |
2024-02-14 6:18 pm Sale | 13G | HARPOON THERAPEUTICS INC N HARP | CITADEL ADVISORS LLC | 1,027,956 6% | -3 (-0.00%) | View |
2024-02-14 6:18 pm Sale | 13G | ENLIVEN THERAPEUTICS INC ELVN | CITADEL ADVISORS LLC | 426,857 0.6% | -1,967,591 (-82.17%) | View |
2024-02-14 6:18 pm Purchase | 13G | VISTAGEN THERAPEUTICS INC VTGN | CITADEL ADVISORS LLC | 1,600,768 5.8% | 6,832 (+0.43%) | View |
2024-02-14 6:18 pm Sale | 13G | GROUPON INC GRPN | CITADEL ADVISORS LLC | 1,273,880 4% | -70,624 (-5.25%) | View |
2024-02-14 6:18 pm Purchase | 13G | ALLURION TECHNOLOGIES INC ALUR | CITADEL ADVISORS LLC | 2,563,726 5.1% | 6,609 (+0.26%) | View |
2024-02-14 6:18 pm Purchase | 13G | INTUITIVE MACHINES, INC. LUNR | CITADEL ADVISORS LLC | 843,505 3.9% | 843,505 (New Position) | View |
2024-02-14 6:18 pm Sale | 13G | APPRECIATE HLDGS INC SFR | CITADEL ADVISORS LLC | 965,611 5.4% | -154,481 (-13.79%) | View |
2024-02-14 6:18 pm Purchase | 13G | ACELYRIN INC SLRN | CITADEL ADVISORS LLC | 6,649,442 6.8% | 685,642 (+11.50%) | View |
2024-02-14 6:18 pm Sale | 13G | BENITEC BIOPHARMA INC BNTC | CITADEL ADVISORS LLC | 95,356 3.6% | -84,674 (-47.03%) | View |
2024-02-14 6:18 pm Sale | 13G | CLENE INC CLNN | CITADEL ADVISORS LLC | 6,050,326 4.5% | -1,574,065 (-20.65%) | View |
2024-02-14 6:18 pm Sale | 13G | APPLIED OPTOELECTRONICS INC CO AAOI | CITADEL ADVISORS LLC | 506,340 1.2% | -1,324,593 (-72.35%) | View |
2024-02-14 4:58 pm Sale | 13G | AEROVATE THERAPEUTICS INC AVTE | CITADEL ADVISORS LLC | 3,276 0% | -1,558,705 (-99.79%) | View |
2024-02-14 4:58 pm Purchase | 13G | DIANTHUS THERAPEUTICS INC DNTH | CITADEL ADVISORS LLC | 2,880 0% | 2,880 (New Position) | View |
2024-02-14 4:58 pm Sale | 13G | FIGS INC FIGS | CITADEL ADVISORS LLC | 611,989 0.4% | -8,605,659 (-93.36%) | View |